Xilio Therapeutics, Inc. Common Stock (NASDAQ: XLO) last traded at $9.23, up 0.00% on the session. The quote above updates while this page is open; the figures below are drawn from Xilio Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Xilio Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker XLO. Its market capitalisation is $53.37 million.
Valuation measures for Xilio Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $53.37M |
|---|---|
| Enterprise value | -$677.4K |
| Price / sales | 0.83 |
| Price / book | 0.74 |
| Beta | 0.93 |
Trailing-twelve-month figures tagged in Xilio Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $64.09M |
|---|---|
| Net income (TTM) | -$21.83M |
| Operating margin | -48.94% |
| Return on equity | -30.21% |
| Cash | $136.04M |
Range and volume for XLO over the past 52 weeks.
| 52-week high | $12.74 |
|---|---|
| 52-week low | $6.47 |
| Volume | 5.1K |
| Average volume | 34.1K |
| Previous close | $9.23 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.